A series of novel, potent, and selective histone deacetylase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 23, 2006, Pages 5948-5952

  Jones, Philip ^a   Altamura, Sergio ^a   Chakravarty, Prasun K ^b   Cecchetti, Ottavia ^a   Francesco, Raffaele De ^a   Gallinari, Paola ^a   Ingenito, Raffaele ^a   Meinke, Peter T ^b   Petrocchi, Alessia ^a   Rowley, Michael ^a   Scarpelli, Rita ^a   Serafini, Sergio ^a   Steinkühler, Christian ^a  

^a IRBM   (Italy)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

HDAC; Histone deacetylase inhibitor; SAR studies

Indexed keywords

APICIDIN; HISTONE DEACETYLASE INHIBITOR;

ARTICLE; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; STRUCTURE ACTIVITY RELATION;

AMIDES; AMINO ACIDS; CELL LINE; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; INDOLES; ISOENZYMES; MOLECULAR STRUCTURE; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33751059239     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.09.002     Document Type: Article

References (20)

1. Johnstone R.W. Nat. Rev. Drug Discov. 1 (2002) 287
2. Cheung W.L., Briggs S.D., and Allis C.D. Curr. Opin. Cell Biol. 12 (2000) 326
3. De Ruijter A.J.M., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B.P. J. Biochem. 370 (2003) 737
4. Minucci S., and Pelicci P.G. Nat. Rev. Cancer 6 (2006) 38
5. Miller T.A., Witter D.J., and Belvedere S. J. Med. Chem. 46 (2003) 5097
6. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., and Kelly W.K. Nat. Rev. Cancer 1 (2001) 194
7. Rosato R.R., and Grant S. Expert Opin. Investig. Drugs 13 (2004) 21
8. Olsen, E.; Kim, Y. H.; Kuzel, T.; Pacheco, T. R.; Foss, F.; Parker, S.; Wang, J. G.; Frankel, S.R.; Lis, J.; Duvic, M. Vorinostat (SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial. Abstract 7500, Annual Meeting of the American Society of Clinical Oncology, Atlanta, Ga., June 2-6, 2006.
9. Vannini A., Volpari C., Filocamo G., Casavola E.C., Brunetti M., Renzoni D., Chakravarty P., Paolini C., De Francesco R., Gallinari P., Steinkühler C., and Di Marco S. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15064
10. Richon V.M., Webb Y., Merger R., Sheppard T., Jursic B., Ngo L., Civoli F., Breslow R., Rifkind R.A., and Marks P.A. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 5705
11. Suzuki T., Ando T., Tsuchiya K., Fukazawa N., Saito A., Mariko Y., Yamashita T., and Nakanishi O. J. Med. Chem. 42 (1999) 3001
12. Frey R.R., Wada C.K., Garland R.B., Curtin M.L., Michaelides M.R., Li J., Pease L.J., Glaser K.B., Marcotte P.A., Bouska J.J., Murphy S.S., and Davidsen S.K. Bioorg. Med. Chem. Lett. 12 (2002) 3443
13. Chen J.S., Faller D.V., and Spanjaard R.A. Curr. Cancer Drug Targets 3 (2003) 219
14. Ueda H., Nakajima H., Hori Y., Fujita T., Nishimura M., Goto T., and Okuhara M. J. Antibiot 47 (1994) 301
15. Darkin-Rattray S.J., Gurnett A.M., Myers R.W., Dulski P.M., Crumley T.M., Allocco J.J., Cannova C., Meinke P.T., Colletti S.L., Bednarek M.A., Singh S.B., Goetz M.A., Dombrowski A.W., Polishook J.D., and Schmatz D.M. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13143
16. 50 were determined using the HDAC Fluorescent Activity Assay, BioMol Research Laboratories (Plymouth Meeting, PA).
17. Anti-proliferation assays were conducted for 72 h using the Promega (Madison, WI) CellTiter-Blue™ Cell Viability Assay. Cells + 10% FCS were grown in 96-well plates, 5000-15,000 cells/well, in the presence of HDACi for 72 h. CellTiter-Blue™ was added, cells were incubated for an hour and read (ex. 550 nm, em. 590 nm).
18. Itazaki H., Nagashima K., Sugita K., Yoshida H., Kawamura Y., Yasuda Y., Matsumoto K., Ishii K., Uotani N., Nakai H., Terui A., Yoshimatsu S., Ikenishi Y., and Nakawaga Y. J. Antibiot. 43 (1990) 1524
19. Incorporating a terminal epoxide into Apicidin's l-Aoda side chain resulted in a dramatic increase in HDAC activity. Colletti S.L., Myers R.W., Darkin-Rattray S.J., Gurnett A.M., Dulski P.M., Galuska S., Allocco J.J., Ayer M.B., Li C., Lim J., Crumley T.M., Cannova C., Schmatz D.M., Wyvratt M.J., Fisher M.H., and Meinke P.T. Bioorg. Med. Chem. Lett. 11 (2001) 107
20. Schöllkopf U. Tetrahedron 39 (1983) 2085